Thursday, September 3, 2015

16:30-16:45	Welcome remarks
16:45-18:45	Gene therapy
Chairperson	Amos Panet, Israel
16:45	Genetic manipulation of solid tissues ex vivo for the sustain production of therapeutic proteins after implantation in patients Amos Panet, Israel
17:15	Treating nervous system tumors with herpes simplex virus Samuel Rabkin, USA
17:45	Gene therapy for hereditary leukodystrophies Nathalie Cartier, France
18:15	The promise and obstacles of gene therapy in muscular dystrophies Thomas Voit, France
18:45-19:30	Keynote lecture
	Genetic enhancements in normal health-eugenics Anjan Chatterjee, USA
19:30-20:30	Networking Reception

Friday, September 4, 2015

08:30-12:20	Animal models as a vehicle to evaluate therapeutic effect in neurological diseases
Chairperson	Israel Steiner, Israel
08:30	Multiple Sclerosis Subramaniam Sriram, USA
08:55	Stroke Michael Chopp, USA
09:20	Parkinson’s disease Olaf Riess, Germany
09:45	Diseases of the synapse: Novel clinical paradigms, models of disease, and therapeutic implications Josep Dalmau, Spain
10:10-10:40	Coffee break and poster viewing
10:40	Muscle disease Mayana Zatz, Brazil
11:05	Alzheimer’s disease Manfred Windisch, Austria
11:30	Ataxia Helen Puccio, France
11:55	How do regulators view animal models? Marlene Haffner, USA

12:20-13:00	Discussion: Animal models: Should we continue to rely solely on them in developing therapies?
Chairpersons	Zohar Argov, Israel Israel Steiner, Israel
Panelists	Subramaniam Sriram, USA Michael Chopp, USA Olaf Riess, Germany Josep Dalmau, Spain Mayana Zatz, Brazil Manfred Windisch, Austria Helen Puccio, France Marlene Haffner, USA
13:00-14:00	Lunch break and poster viewing

14:00-16:30	Movement disorders and behavioural neurology
Chairperson	Elio Scarpini, Italy
14:00	Dementia: If and how to treat psycho-behavioural disturbances Alfredo Carlo Altamura, Italy
14:30	The treatment of extra nigral symptomatology involvement in Parkinson's disease Ivan Rektor, Czech Republic
15:00-15:30	Coffee break and poster viewing
15:30	The diagnosis and treatment of FTD Yolande Pijnenburg, The Netherlands
16:00	The perspectives of new disease-modifying strategies Elio Scarpini, Italy

16:30-17:15	Round Table Discussion: Therapy of orphan neurological diseases
Chairperson	Zohar Argov, Israel
16:30 16:40 16:50 17:00	John Richert, USA Marlene Haffner, USA Paul Matthews, UK Discussion
17:15-18:00	The provocation of the day
	Regulatory balance: Are we impeding neurological research? Efrat Levi-Lahad, Israel

Saturday, September 5, 2015

08:30-09:20	Round Table Discussion: Length of Multiple Sclerosis pivotal studies
Chairperson	Israel Steiner, Israel
08:30 08:40 08:50 09:00	Nancy Richert, USA Ludwig Kappos, Switzerland David Leppert, Switzerland Discussion

09:20-10:00	Round Table Discussion: Informed consent in Alzheimer's disease and other dementing conditions
Chairperson	Israel Steiner, Israel
09:20 09:30 09:40	Anjan Chatterjee, USA Efrat Levi-Lahad, Israel Discussion
10:00-10:30	Coffee break and poster viewing

10:30-12:30	Neuro infections
Chairperson	Avindra Nath, USA
10:30	Therapy of lyme and post lyme disease syndrome Andrew Pachner, USA
11:00	PML: Prevention, diagnosis and therapy Nancy Richert, USA
11:30	Issues in the treatment of neurological conditions caused by reactivation of Varicella-Zoster Virus (VZV) Peter Kennedy, UK
12:00	Therapy of neuroAIDS Avindra Nath, USA

12:30-13:00	Free Communications
12:30-12:45	A double-blind, randomized, versus-placebo study, in order to evaluate efficacy of the ultra-micronized palmitoylethanolamide in reducing interferonb-1A related side effects in relapsing remitting Multiple Sclerosis Nicola Salvatore Orefice, Italy
	Discussant: Moses Rodriguez, USA
12:45-13:00	Brain-derived neurotrophic factor (BDNF) enhance therapeutic effects of human adipose stem cells (ADSC) in ALS rat model Hong J. Lee, Korea
	Discussant: Amos Panet, Israel
13:00-14:00	Lunch break and poster viewing

14:00-17:30	Future neurotherapeutics
Chairperson	Louis Caplan, USA
14:00	Multiple sclerosis Moses Rodriguez, USA
14:30	Stroke Louis Caplan, USA
15:00	Infections David Clifford, USA
15:30	Peripheral neuropathies David Cornbalth, USA
16:00-16:15	Coffee break and poster viewing
16:15	Alzheimer's disease Nathalie Cartier, France
16:45	The near future of neurotherapeutics in headache disorders Morris Levin, USA
17:15	Cerebellar ataxias Massimo Pandolfo, Belgium

17:45-18:30

Flash Oral Session

Sunday, September 6, 2015

8:30-12:00	Management dilemmas in neuroimmunological conditions
Chairperson	Nicola De Stefano, Italy
8:30	Multiple sclerosis: What to do with the patient with no evidence for disease activity Nicola De Stefano, Italy
9:00	Acute myelitis and NMO: What is the right treatment? Brian Weinshenker, USA
9:30	Primary CNS vasculitis: Challenges in diagnosis and treatment Nicolo Pipitone, Italy
10:00-10:30	Coffee break and poster viewing
10:30	Thymectomy in MG Gil Wolfe, USA
11:00	Necrotizing autoimmune myopathy Marianne De Visser, The Netherlands
11:30	Treatment dilemmas for multifocal motor neuropathy without conduction blocks David Cornblath, USA
12:00-12:30	Summary and closure Presentation of Young Scientist Award